Robert Dempsey
Tracked across 3 events · 22 articles · First seen May 19, 2026 · Last active Jul 08, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Regulatory
Impact: Robert Dempsey, CEO, emphasized the company's strong balance sheet and regulatory clarity enabling advancement into the global Phase 3 trial.
Jul 08, 2026 · 9 articles
Business
Impact: Robert Dempsey>>>, CEO of OKYO Pharma>>>, announced the appointment of Marta Sacchetti>>> to the Scientific Advisory Board.
May 19, 2026 · 7 articles
Business
Impact: CEO of OKYO Pharma, presenting at the symposium.
Jul 07, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Robert Dempsey live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard